Research map: BAP1 and PTEN mutations shape the immunological landscape of clear cell renal cell carcinoma and reveal the intertumoral heterogeneity of T cell suppression: a proof-of-concept study

Back to the article

Papers in this map

  1. Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing · Marco Gerlinger · 2012 · 7928 citations · Cited by this paper
  2. Pan-cancer proteogenomics characterization of tumor immunity · Francesca Petralia · 2024 · 98 citations · Cites this paper
  3. HBO1 suppresses anti-tumor immunity of CD8⁺ T Cells in thyroid cancer by recruiting BRD4 to regulate VTCN1 expression · 2026 · Related
  4. Understanding the tumor immune microenvironment (TIME) for effective therapy · Mikhail Binnewies · 2018 · 6348 citations · Cited by this paper
  5. Genomic Profiling and Molecular Characterization of Clear Cell Renal Cell Carcinoma · Gaetano Pezzicoli · 2023 · 24 citations · Cites this paper
  6. Conserved minimal CD8 cytotoxic immune-state unit in an IL18R1-associated immune program in hepatocellular carcinoma · 2026 · Related
  7. Comprehensive molecular characterization of clear cell renal cell carcinoma · Chad J. Creighton · 2013 · 3607 citations · Cited by this paper
  8. Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma · Richard Culliford · 2024 · 16 citations · Cites this paper
  9. Impact of neck nodal yield on immune checkpoint inhibitor outcome after recurrence in head and neck squamous cell carcinoma · 2026 · Related
  10. The immune contexture in cancer prognosis and treatment · Wolf H. Fridman · 2017 · 2375 citations · Cited by this paper
  11. Digital Spatial Profiling Identifies the Tumor Periphery as a Highly Active Biological Niche in Clear Cell Renal Cell Carcinoma · Felix Schneider · 2023 · 12 citations · Cites this paper
  12. Preclinical efficacy of iPSC-derived MUC1-targeted CAR-NK cells against esophageal squamous cell carcinoma · 2026 · Related
  13. Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer · Anthony Richard Cillo · 2020 · 700 citations · Cited by this paper
  14. Genetic alterations shape innate immune cells to foster immunosuppression and cancer immunotherapy resistance · Louis Boafo Kwantwi · 2023 · 9 citations · Cites this paper
  15. Survival outcomes of conversion curative therapy following atezolizumab–bevacizumab in advanced hepatocellular carcinoma · 2026 · Related
  16. Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal · Samra Turajlic · 2018 · 692 citations · Cited by this paper
  17. Decoding PTEN regulation in clear cell renal cell carcinoma: Pathway for biomarker discovery and therapeutic insights · Ângela Alves · 2024 · 9 citations · Cites this paper
  18. Integrative single-cell and multi-omics analysis of ZBTB21-mediated serine metabolism in colorectal cancer: from metabolic reprogramming to immune microenvironment modulation · 2026 · Related
  19. Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade · Robert John Motzer · 2020 · 586 citations · Cited by this paper
  20. Immune landscape of renal cell carcinoma with metastasis to the pancreas · Maximilian Kippenberger · 2024 · 7 citations · Cites this paper
  21. Squeezing Treatment-Induced Metabolic Alterations in Melanoma Cells Are Accompanied by Impaired Cluster of Differentiation 8-Positive T Cell and Natural Killer Cell Antitumor Effector Functions · 2026 · Related
  22. Progressive immune dysfunction with advancing disease stage in renal cell carcinoma · David A. Braun · 2021 · 542 citations · Cited by this paper
  23. Spatial expression of fibroblast activation protein-α in clear cell renal cell carcinomas revealed by multiplex immunoprofiling analysis of the tumor microenvironment · Gorka Larrinaga · 2025 · 7 citations · Cites this paper
  24. Efficacy and safety of anti-PD-1 combined with IFN-α1b with or without anlotinib as the first-line therapy in patients with unresectable advanced melanoma: a real-world cohort study · 2026 · Related
  25. Dissecting the mechanisms of immune checkpoint therapy · Padmanee Sharma · 2020 · 462 citations · Cited by this paper
  26. Current trends in the promising immune checkpoint inhibition and radiotherapy combination for locally advanced and metastatic urothelial carcinoma · Takeshi Sano · 2023 · 5 citations · Cites this paper
  27. Spatially fractionated radiotherapy with PD-L1 blockade achieves superior antitumor efficacy and safety in a preclinical model of peritoneal metastasis · 2026 · Related
  28. Therapeutic targeting of regulatory T cells in cancer · Feng Shan · 2022 · 249 citations · Cited by this paper
  29. SPP1+ Neutrophils Mediate Resistance to Immune Checkpoint Blockade in BAP1-Inactivated Tumors · Jiahao Shi · 2025 · 5 citations · Cites this paper
  30. Emerging role of PTEN loss in evasion of the immune response to tumours · Thiago Vidotto · 2020 · 215 citations · Cited by this paper
  31. PD-L1 as a Urine Biomarker in Renal Cell Carcinoma—A Case Series and Proof-of-Concept Study · Philipp Reimold · 2024 · 3 citations · Cites this paper
  32. Untitled · Cited by this paper
  33. Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study · Jakob Wieke · 2025 · 1 citation · Cites this paper
  34. Untitled · Cited by this paper
  35. Deep spatial proteomics reveals a suppressive immune niche linked to immune evasion in renal cell carcinoma · Yujia Zhang · 2026 · Cites this paper
  36. Untitled · Cited by this paper
  37. Establishing a prognostic model based on five starvation-related long non-coding RNAs for clear cell renal cell carcinoma · Yu Jerry Zhou · 2023 · Cites this paper
  38. Untitled · Cited by this paper
  39. Untitled · Cited by this paper

Source: OpenAlex (CC0)